Miralles, Cristina
Miñana, María Dolores
Nieto, María Luisa
del Carmen Aguar, María
Domínguez-Márquez, Victoria
Soler-Cataluña, Juan José
Funding for this research was provided by:
Valencian Pneumology Society (UGP-19-483)
GlaxoSmithKline (CPRES00124)
Article History
Received: 16 June 2025
Accepted: 27 October 2025
First Online: 14 February 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Arnau de Vilanova Hospital, Valencia, Spain. All participants gave their informed consent.
: Not applicable.
: JJSC has received speaker fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, FAES, GlaxoSmithKline, Grifols, Menarini and Sanofi, and consulting fees from AstraZeneca, Bial, Chiesi, GSK, Grifols and Sanofi, and grants from GSK. The rest of authors declare no competing interests.